TechNavio Announces the Publication of its Report – Injectable Drugs Market in the US 2011–2015
TechNavio today launched its report Injectable Drugs Market in the US 2011–2015 based on an in-depth study focusing exclusively on the US. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare said; “Injectable drugs are administered into the body through the intravenous delivery method. Vendors are continuously upgrading their injecting devices to ensure safety and to reduce pain. Moreover, vendors are developing pre-filled syringes that provide greater accuracy in delivering the injectable drugs into the body. Such devices eliminate the common risk of administering high doses to the patients, which can cause adverse side effects.”
According to the report, there has been an increase in the prevalence of people suffering from different musculoskeletal diseases such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis in the US. This has created high demand for injectable drugs in the US because they are more effective in the treatment of these diseases than the other forms of drugs available in the market. This is one of the major drivers contributing to the growth of the market.
Further, the report also discusses that the problems associated with the storage of injectable drugs is a major challenge to the growth of the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit http://technavio.com/content/injectable-drugs-market-us-2011-2015
Follow us on Twitter @ Technavio